BSECompany Update13 Sept 2026 · 13 Sept 2026, 04:32 pm
Acquisition of Gland Pharma USA Inc., a wholly-owned Step down subsidiary from Gland Pharma International Pte. Ltd, a wholly-owned subsidiary of the Company
Gland Pharma Ltd · 543245
✦ AI SummaryM&A
Gland Pharma Ltd has announced the acquisition of 100% equity share capital of Gland Pharma USA Inc., a wholly-owned step-down subsidiary, from Gland Pharma International Pte. Ltd, a wholly-owned subsidiary of the Company. The acquisition is expected to be completed by October 31, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst6/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Gland Pharma Ltd - 543245 - Announcement under Regulation 30 (LODR)-Acquisition